# US 2013/0280810 A1 · Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0280810 A1
- Document ID: US20130280810A1
- Status: Published application
- Kind: A1
- Application number: 13/919,952
- Filed: 2013-06-17
- Published: 2013-10-24
- Earliest claimed: 2001-02-23
- Assignees: Universite Libre de Bruxelles
- Applicants: Universite Libre de Bruxelles
- Inventors: Philippe Gabant; Laurence Van Melderen; Cedric Yves Szpirer
- Web page: https://patentgrep.com/patent/US20130280810A1

## CPC

- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C07K 14/245: Escherichia (G)
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/1034: {Isolating an individual clone by screening libraries}
- C12N 15/65: using markers (enzymes used as markers C12N15/52)
- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention is related to a method for the selection of recombinant clones having integrated a gene of interest and a nucleotide sequence encoding a functional antidote protein to a toxic molecule, wherein said recombinant clones are the ones which survive following their integration into a host cell comprising in its genome a nucleotide sequence encoding said toxic molecule. The present invention is also related to a nucleic acid construct, a vector comprising said nucleic acid construct, a host cell and a cloning and/or sequencing kit for performing said method.

## Claims

### Claim 1

A method for the selection of recombinant clones, said method comprising:
obtaining a prokaryotic host cell comprising in its genome a nucleotide sequence encoding a poison protein; and
introducing into said host cell a DNA insert and a nucleotide sequence encoding a functional antidote protein to the poison protein, wherein said recombinant clones are the ones which survive following introduction of said DNA insert and said nucleotide sequence encoding the functional antidote protein to the poison protein into the host cell,
wherein the antidote and poison proteins are selected from the group consisting of the following coupled proteins: CcdA/CcdB protein, K is/Kid protein, Phd/Doc protein, RelB/relE protein, PasB/PasA protein, PasC/PasA protein and mazE/mazF protein.

### Claim 2 (depends on 1)

The method of claim 1, wherein said nucleotide sequence encoding the antidote protein to the poison protein is reconstituted from a nucleotide sequence encoding an inactive antidote protein following integration of the DNA insert.

### Claim 3 (depends on 1)

The method of claim 1, further comprising recovering one or more recombinant clones.

### Claim 4 (depends on 1)

The method of claim 1, wherein the nucleotide sequence encoding the antidote protein to the poison protein is expressed following introduction of the insert that comprises a promoter/operator sequence.

### Claim 5 (depends on 1)

The method of claim 1, wherein the nucleotide sequence encoding the antidote protein to the poison protein is expressed following introduction of the insert that comprises a transcriptional and/or translational signal of the nucleotide sequence encoding the antidote protein to the poison protein.

### Claim 6 (depends on 1)

The method of claim 1, wherein the nucleotide sequence encoding the antidote protein to the poison protein is a first nucleotide fragment encoding an inactive antidote protein that is rendered functional following introduction of the insert that comprises a second nucleotide fragment of the nucleotide sequence encoding the antidote protein to the poison protein and that reconstitutes a functional antidote protein to the poison protein.

### Claim 7 (depends on 6)

The method of claim 6, wherein said DNA insert brings a sequence comprising a transcriptional and/or translational signal that allows the expression of the antidote protein or wherein the DNA insert integrates another nucleotide sequence encoding the antidote protein, a portion of the antidote protein or a C-terminal, transcriptional or translational signal of the antidote protein.
